Natera Revenue 2014-2024 | NTRA
Natera annual/quarterly revenue history and growth rate from 2014 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Natera revenue for the quarter ending September 30, 2024 was $0.440B, a 63.9% increase year-over-year.
- Natera revenue for the twelve months ending September 30, 2024 was $1.532B, a 54.94% increase year-over-year.
- Natera annual revenue for 2023 was $1.083B, a 31.99% increase from 2022.
- Natera annual revenue for 2022 was $0.82B, a 31.13% increase from 2021.
- Natera annual revenue for 2021 was $0.625B, a 59.97% increase from 2020.
| Natera Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,083 |
| 2022 | $820 |
| 2021 | $625 |
| 2020 | $391 |
| 2019 | $302 |
| 2018 | $258 |
| 2017 | $210 |
| 2016 | $213 |
| 2015 | $190 |
| 2014 | $159 |
| 2013 | $55 |
| Natera Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $440 |
| 2024-06-30 | $413 |
| 2024-03-31 | $368 |
| 2023-12-31 | $311 |
| 2023-09-30 | $268 |
| 2023-06-30 | $261 |
| 2023-03-31 | $242 |
| 2022-12-31 | $217 |
| 2022-09-30 | $211 |
| 2022-06-30 | $198 |
| 2022-03-31 | $194 |
| 2021-12-31 | $173 |
| 2021-09-30 | $158 |
| 2021-06-30 | $142 |
| 2021-03-31 | $152 |
| 2020-12-31 | $112 |
| 2020-09-30 | $98 |
| 2020-06-30 | $86 |
| 2020-03-31 | $94 |
| 2019-12-31 | $83 |
| 2019-09-30 | $78 |
| 2019-06-30 | $74 |
| 2019-03-31 | $67 |
| 2018-12-31 | $67 |
| 2018-09-30 | $65 |
| 2018-06-30 | $63 |
| 2018-03-31 | $62 |
| 2017-12-31 | $52 |
| 2017-09-30 | $56 |
| 2017-06-30 | $52 |
| 2017-03-31 | $49 |
| 2016-12-31 | $45 |
| 2016-09-30 | $54 |
| 2016-06-30 | $52 |
| 2016-03-31 | $62 |
| 2015-12-31 | $53 |
| 2015-09-30 | $45 |
| 2015-06-30 | $45 |
| 2015-03-31 | $47 |
| 2014-12-31 | |
| 2014-09-30 | $46 |
| 2014-06-30 | $36 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.104B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $88.397B | 10.97 |
| Cencora (COR) | United States | $45.651B | 17.16 |
| DiDi Global (DIDIY) | China | $21.969B | 0.00 |
| ICON (ICLR) | Ireland | $18.002B | 16.03 |
| Avantor (AVTR) | United States | $14.742B | 22.10 |
| Viatris (VTRS) | United States | $13.929B | 4.29 |
| Revvity (RVTY) | United States | $13.859B | 24.08 |
| BioMerieux (BMXMF) | France | $12.558B | 0.00 |
| CochLear (CHEOY) | Australia | $12.074B | 0.00 |
| Solventum (SOLV) | United States | $11.587B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.906B | 30.72 |
| Doximity (DOCS) | United States | $9.727B | 57.25 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.707B | 0.00 |
| Charles River Laboratories (CRL) | United States | $9.517B | 18.39 |
| HealthEquity (HQY) | United States | $8.694B | 43.62 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.259B | 29.11 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Organon (OGN) | United States | $4.082B | 4.12 |
| Sotera Health (SHC) | United States | $3.713B | 19.86 |
| BrightSpring Health Services (BTSG) | United States | $2.990B | 63.59 |
| Surgery Partners (SGRY) | United States | $2.625B | 29.93 |
| Concentras Parent (CON) | United States | $2.513B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.455B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.277B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.255B | 0.00 |
| Premier (PINC) | United States | $2.006B | 10.44 |
| PACS (PACS) | United States | $1.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.734B | 45.50 |
| Teladoc Health (TDOC) | United States | $1.699B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.658B | 0.00 |
| Progyny (PGNY) | United States | $1.597B | 32.34 |
| Establishment Labs Holdings (ESTA) | $1.282B | 0.00 | |
| CareDx (CDNA) | United States | $1.267B | 0.00 |
| Embecta (EMBC) | United States | $1.132B | 7.92 |
| Pediatrix Medical (MD) | United States | $1.068B | 10.45 |
| AMN Healthcare Services Inc (AMN) | United States | $1.023B | 6.93 |
| Agilon Health (AGL) | United States | $1.001B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.563B | 14.73 |
| SBC Medicals (SBC) | United States | $0.526B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.526B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.490B | 0.00 |
| DocGo (DCGO) | United States | $0.416B | 15.69 |
| Sonida Senior Living (SNDA) | United States | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.242B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.234B | 0.00 |
| MultiPlan (MPLN) | United States | $0.206B | 0.00 |
| LifeMD (LFMD) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.197B | 0.00 |
| Beauty Health (SKIN) | United States | $0.192B | 0.00 |
| Biodesix (BDSX) | United States | $0.185B | 0.00 |
| Nutex Health (NUTX) | United States | $0.168B | 0.00 |
| So-Young (SY) | China | $0.104B | 17.70 |
| ModivCare (MODV) | United States | $0.094B | 5.09 |
| Ascend Wellness Holdings (AAWH) | United States | $0.092B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |